Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

New 2013 iPSC Industry Report Details Market Trends, Metrics and Financials

Published: Friday, September 20, 2013
Last Updated: Friday, September 20, 2013
Bookmark and Share
Report provides strategic insights that guide the decision-making of companies that develop and manufacture induced pluripotent stem cell research products.

BioInformant Worldwide, LLC, has recently released the market intelligence report titled “The Complete 2012-13 Induced Pluripotent Stem Cell (iPSC) Industry Report.”  

The market intelligence report presents financial metrics for the Induced Pluripotent Stem Cell Industry, as well as key findings discovered from surveying a global audience of iPSC researchers (293 respondents). It reveals iPSC product and industry trends with five-year projections; informs about iPSC grants, patents and publications; identifies profitable opportunities for producers of iPSC products, and presents critical insights into future tools that iPSC scientists will require. In addition, it clearly denotes preferred species for iPSC research, analyzes the competitive environment for iPSC research products, and breaks down market share by competitor – providing an overall view of the iPSC product landscape. 

iPSCs are adult stem cells that have been transformed into embryotic-like stem cells through the manipulation of gene expression and similar methods. Despite some initial concerns, induced pluripotent stem cells (iPSC) are now sold by more than half (53.4%) of U.S. research product companies and 38.7% of research product companies worldwide.

"It is clear that iPSC products are in high demand within the scientific community. Currently, it is difficult for stem cell research product suppliers, like BD BioSciences, Life Technologies, and others, to know what products iPSC scientists will demand in 2013 and beyond. The needs of scientists are constantly changing, so this market intelligence report reveals profitable opportunities for providers of iPSC research products to pursue,” says BioInformant. 

For the past five decades, stem cell research has provided insights to the inner workings of the body and cell regeneration. “Therapeutic applications of iPSCs represent the future of medicine," says BioInformant. The scientific community believes that one day stem cell research will assist in finding viable treatments for crippling diseases such as Parkinson’s, Alzheimer’s, spinal cord injuries and more.  

“This is a must-read industry report for research supply companies to optimally position themselves to sell iPSC research products. This is a lucrative and rapidly expanding market,” explains BioInformant.  “The study will help you understand your key strengths relative to the competition.”

The study is backed by a 100% money back guarantee, to ensure that the strategies, findings and tools are found helpful.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flow Chemistry Market by Reactor Type, Application & Geography - Trends & Forecast to 2018
Market estimated at $709.5 million and expected to reach $1,216.1 million by 2018 growing at CAGR of 9.4%.
Friday, April 11, 2014
DNA and RNA Isolation Techniques: Market Developments, Growth Areas and Opportunities
Report highlights that the use of kit-based isolation methods is expected to grow by 16% in the next three years.
Friday, October 18, 2013
Antibiotic Resistance 2013: A Global Market Study
Just ten antibiotic classes are being used to treat 86% of all bacterial infections.
Friday, October 18, 2013
Scientific News
Breaking Through the Barriers to Lab Innovation
Here we examine the drivers behind the move for greater innovation, the challenges and current trends in laboratory informatics, and the tools that can be used to break these barriers.
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Gene Editing Could Enable Pig-To-Human Organ Transplant
The largest number of simultaneous gene edits ever accomplished in the genome could help bridge the gap between organ transplant scarcity and the countless patients who need them.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Adult High Blood Pressure Risk Identifiable in Childhood
Groups of people at risk of having high blood pressure and other related health issues by age 38 can be identified in childhood, new University of Otago research suggests.
Analyzing Protein Structures in Their Native Environment
Enhanced-sensitivity NMR could reveal new clues to how proteins fold.
Supercoiled DNA is Far More Dynamic Than the “Watson-Crick” Double Helix
Researchers have imaged in unprecedented detail the three-dimensional structure of supercoiled DNA, revealing that its shape is much more dynamic than the well-known double helix.
Mini-kidneys Successfully Grown from Stem Cells
Researchers from Murdoch Childrens Research Institute have perfected a method of turning stem cells into mini-kidneys for use in drug screening, disease modelling and cell therapy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos